Board Stats

Karyopharm Therapeutics, Inc.

KPTI / Message Board

BOARD

GROUPS

Written By On Topic Only -- All Messages

Hide Replies

Keyword
Subject

Between			and
Rec'd By

Authored By
Minimum Recs

MSG #	SUBJECT	TYPE	AUTHOR	SENTIMENT	RECS	DATE POSTED
76	$KPTI Antengene Announces the Approval of First-in-Class Oral XPO1 Inhibitor Selinexor in South Korea for the Treatment of Relapsed or Refractory Multiple Myeloma and Diffuse Large B-Cell Lymphoma	GN	Biotech2050		1	8/1/2021 12:49:11 PM

75	Karyopharm Announces Dosing of First Patients in Two New Company-Sponsored Clinical Studies in Melanoma and Myelofibrosis	GN	jerrykrause		1	7/29/2021 6:42:41 PM

74	Karyopharms KPT-9274 chances to transition to next stage of development in multiple oncology indications plunge after termination of Phase I basket trial	GN	jerrykrause		0	7/8/2021 12:56:54 PM

73	selinexor + Nivo + Ipi trial posted	GN	kapshubhrata		2	4/22/2021 12:43:38 AM

72	earning date and predictions	GN	kapshubhrata		0	4/21/2021 7:25:38 PM

71	Re: Morgan Stanley increases stake in KPTI	GN	kapshubhrata		0	4/21/2021 6:25:09 PM

70	Re: Morgan Stanley increases stake in KPTI	GN	rational1_2000		0	4/21/2021 4:46:43 PM

69	Re: Morgan Stanley increases stake in KPTI	GN	kapshubhrata		0	4/21/2021 1:14:29 PM

68	Morgan Stanley increases stake in KPTI	GN	rational1_2000		1	4/21/2021 8:26:40 AM

67	Selinexor, Bortezomib, and Dexamethasone Combination Proves Effective for Myeloma	GN	rational1_2000		3	4/7/2021 1:49:06 PM

Go to Msg #

BOARDS Sign In for Filters